Clinical Trials Directory

Trials / Completed

CompletedNCT00426010

Measuring Placebo Effect by Elimination and Investigating Mechanism of Action

Measuring Placebo Effect by Elimination and Investigating Its Mechanism of Action

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
King Faisal Specialist Hospital & Research Center · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

We propose to measure the effect of placebo by elimination as well as by a "balanced placebo" design, determine its interaction with active drug, and explore whether placebo exerts part of its effect at the pharmacokinetics level.

Detailed description

Placebos have been in use for centuries in medical practice. However, there is continued controversy regarding their effectiveness and mechanisms of action. The results of the study are expected to further our understanding of a widely used medical intervention, i.e., placebo, and of how to maximize its potential beneficial effect. It will also help assess the appropriateness of measuring the placebo effect by elimination, which has important ethical implications in relation to the design of randomized clinical trials. Comparison: caffeine vs placebo. Dependent variables:4 hours area under the curve (AUC) of pharmacodynamics endpoints as well as pharmacokinetics endpoints in a subgroup.

Conditions

Interventions

TypeNameDescription
DRUGcaffeine/placebocaffeine or placebo, either overt or covert

Timeline

Start date
2007-01-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2007-01-24
Last updated
2011-12-13

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT00426010. Inclusion in this directory is not an endorsement.